Continuous 5-fluorouracil infusion plus long acting octreotide in advanced well-differentiated neuroendocrine carcinomas. A phase II trial of the Piemonte Oncology Network

BACKGROUND: Well-differentiated neuroendocrine carcinomas are highly vascularized and may be sensitive to drugs administered on a metronomic schedule that has shown antiangiogenic properties. A phase II study was designed to test the activity of protracted 5-fluorouracil (5FU) infusion plus long-act...

詳細記述

保存先:
書誌詳細
主要な著者: Brizzi, Maria P, Berruti, Alfredo, Ferrero, Anna, Milanesi, Enrica, Volante, Marco, Castiglione, Federico, Birocco, Nadia, Bombaci, Sebastiano, Perroni, Davide, Ferretti, Benedetta, Alabiso, Oscar, Ciuffreda, Libero, Bertetto, Oscar, Papotti, Mauro, Dogliotti, Luigi
フォーマット: Artigo
言語:Inglês
出版事項: BioMed Central 2009
主題:
Research Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2776604/
https://ncbi.nlm.nih.gov/pubmed/19886987
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-9-388
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料